Trendy ‘targeted therapy’ working on ulcerative colitis treatment too

‘Targeting’ has been a trend in the new drug development market for the past several years. New drugs had been developed with a mechanism of affecting the entire body, but the new drug paradigm is now changing to affecting only on organs or tissues to treat.

Recently, another ‘targeted’ drug was developed. Launched in Korea on the last 1^st, Takeda Pharmaceutical’s ‘Kynteles Inj(generic name: v...